CD274 and neoplasm: PD-1/PD-L1 checkpoint inhibition suppresses PD-L1 negative tumors by interfering with platelet PD-L1 binding, and inhibition in PD-L1 negative tumor growth has been observed upon platelet depletion associated with a decrease in platelet PD-L1 secretion (Zaslavsky et al., 2020).